As Forbion marks its 20th anniversary, Managing Partner Sander Slootweg joined Philip Hemme on the Flot.bio podcast, recorded live at Bio-Europe Spring in Lisbon.
In a wide-ranging, investor-focused discussion, Sander traces Forbion’s evolution from its first funds to a leading European life sciences platform managing over €5 billion in assets. He outlines the strategy behind building one of Europe’s largest biotech growth vehicles, the €1.2 billion Growth Opportunities Fund III, and reflects on how two decades of market cycles have reshaped the European biotech investment landscape.
Watch the full interview below: